Connor, Clark & Lunn Investment Management »

Dyne Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 41k 35.92
2023-03-31 $242k 21k 11.52

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
Enbridge (ENB)
Agnico (AEM)
Canadian Natl Ry (CNI)
Thomson Reuters Corp. (TRI)
Shopify Cl A (SHOP)
Bk Nova Cad (BNS)
Canadian Pacific Kansas City (CP)
Suncor Energy (SU)
Waste Connections (WCN)
Canadian Natural Resources (CNQ)
Manulife Finl Corp (MFC)
Tc Energy Corp (TRP)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics